Medpace Holdings, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Medpace Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2015 to Q3 2024.
  • Medpace Holdings, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $6.5M.
  • Medpace Holdings, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $23.9M.
  • Medpace Holdings, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.14M, a 127% decline from 2022.
  • Medpace Holdings, Inc. annual Nonoperating Income (Expense) for 2022 was $4.16M, a 28.6% increase from 2021.
  • Medpace Holdings, Inc. annual Nonoperating Income (Expense) for 2021 was $3.24M, a 117% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $23.9M $6.5M +$8.21M Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-22
Q2 2024 $15.7M $5.33M +$7.98M Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-23
Q1 2024 $7.74M $8.71M +$8.89M Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-23
Q4 2023 -$1.14M $3.39M +$6.17M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-13
Q3 2023 -$7.32M -$1.71M -$5.77M -142% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-22
Q2 2023 -$1.54M -$2.65M -$4.41M -250% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-23
Q1 2023 $2.87M -$174K -$1.3M -116% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-23
Q4 2022 $4.16M -$2.79M -$3.85M -361% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-13
Q3 2022 $8.02M $4.07M +$3.04M +297% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-24
Q2 2022 $4.97M $1.76M +$1.53M +641% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-25
Q1 2022 $3.45M $1.12M +$211K +23.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-25
Q4 2021 $3.24M $1.07M +$1.35M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-13
Q3 2021 $1.89M $1.02M +$455K +80.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-25
Q2 2021 $1.43M $238K +$4K +1.71% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-26
Q1 2021 $1.43M $910K -$64K -6.57% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-26
Q4 2020 $1.49M -$286K -$385K -389% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-14
Q3 2020 $1.88M $568K +$1.09M Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-26
Q2 2020 $781K $234K +$1M Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-27
Q1 2020 -$220K $974K +$2.21M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-27
Q4 2019 -$2.43M $99K +$1.45M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-15
Q3 2019 -$3.88M -$526K +$933K +63.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-27
Q2 2019 -$4.81M -$767K +$1.06M +58.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-28
Q1 2019 -$5.87M -$1.24M +$1.23M +49.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 -$7.1M -$1.35M +$417K +23.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-16
Q3 2018 -$7.51M -$1.46M +$592K +28.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-29
Q2 2018 -$8.11M -$1.83M +$103K +5.33% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 -$8.21M -$2.46M -$296K -13.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-30
Q4 2017 -$7.91M -$1.76M +$10.9M +86.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 -$18.8M -$2.05M +$2.98M +59.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 -$21.8M -$1.93M +$3.99M +67.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 -$25.8M -$2.17M +$4.74M +68.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 -$30.5M -$12.7M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 -$5.03M +$1.65M +24.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 -$5.93M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 -$6.91M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q3 2015 -$6.69M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.